This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n11http://linked.opendata.cz/resource/drugbank/drug/DB07348/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB07348/identifier/chemspider/
n7http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n6http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07348/identifier/pdb/
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n14http://linked.opendata.cz/resource/drugbank/drug/DB07348/identifier/pubchem-compound/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07348/identifier/pubchem-substance/

Statements

Subject Item
n2:DB07348
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n6:DB07348 n7:DB07348
dcterms:title
1,6,7,8,9,11A,12,13,14,14A-DECAHYDRO-1,13-DIHYDROXY-6-METHYL-4H-CYCLOPENT[F]OXACYCLOTRIDECIN-4-ONE
adms:identifier
n10:4449949 n11:DB07348 n12:99443819 n13:AFB n14:5287620
n3:IUPAC-Name
n4:271B62AC-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B62B2-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B62B1-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B62AE-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B62AF-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B62B0-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B62AA-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B62A8-363D-11E5-9242-09173F13E4C5 n4:271B62AB-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B62A9-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B62B8-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B62B9-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B62B3-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B62B4-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B62B6-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B62B5-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B62B7-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B62BE-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B62C0-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B62C1-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B62BD-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B62BC-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B62BF-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B62AD-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B62BA-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B62BB-363D-11E5-9242-09173F13E4C5